ArticleHepatitis monthly2015

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.

Pierre Pradat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.